# Combination Chemotherapy With or Without Veliparib in Treating Patients With Stage IV Head and Neck Cancer

> **NCT01711541** · PHASE1,PHASE2 · COMPLETED · sponsor: **National Cancer Institute (NCI)** · enrollment: 24 (actual)

## Conditions studied

- Head and Neck Squamous Cell Carcinoma
- Stage IVA Oropharyngeal Carcinoma AJCC v7
- Stage IVB Oropharyngeal Carcinoma AJCC v7

## Interventions

- **DRUG:** Carboplatin
- **DRUG:** Cisplatin
- **DRUG:** Fluorouracil
- **DRUG:** Hydroxyurea
- **OTHER:** Laboratory Biomarker Analysis
- **DRUG:** Paclitaxel
- **OTHER:** Placebo Administration
- **RADIATION:** Radiation Therapy
- **DRUG:** Veliparib

## Key facts

- **NCT ID:** NCT01711541
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-10-22
- **Primary completion:** 2018-02-15
- **Final completion:** 2023-05-15
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2023-06-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01711541

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01711541, "Combination Chemotherapy With or Without Veliparib in Treating Patients With Stage IV Head and Neck Cancer". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01711541. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*